期刊文献+

肌钙蛋白Ⅰ在急性心肌梗死早期诊断和心肌再梗死中的价值 被引量:1

The early diagnostic value of cardiac troponin I in acute myocardial infarction and myocardial reinfarction
下载PDF
导出
摘要 目的探讨心肌肌钙蛋白I(cTnI)在急性心肌梗死(AMI)早期诊断和心肌再梗死中的价值。方法测定131例AMI发作2~10 h患者的血清cTnI和肌酸激酶同工酶(CK-MB)的浓度,并以122名健康体检者作对照,绘制并分析受试者工作特征(ROC)曲线。结果AMI组发病早期血清cTnI和CK-MB水平与对照组相比差异有统计学意义(P<0.01);AMI后2~10 h cTnI和CK-MB的ROC曲线下面积(AUC)分别为:0.925、0.991、0.998和0.648、0.719、0.831;在AMI后2~10 h cTnI和CK-MB各指标临界值对应的敏感度分别为90.6%、97.6%、97.7%和54.1%、56.9%、76.9%;特异度分别为87.3%、95.4%、98.5%和87.3%、93.5%、88.1%;AMI发作10 h的患者若cTnI>20.1μg/L时,心肌再梗死与cTnI相关性良好(r=0.74)。结论cTnI在AMI早期诊断和预测再梗死中有一定的应用价值。 Objective To investigate the early diagnostic values of cardiac troponin Ⅰ (cTnI) in acute myocardial infarction(AMI). Methods The levels of cTnI and MB isoenzyme of creatine kinase (CK-MB) in 131 patients with AMI from 2 h to 10 h were detected, in comparison with 122 normal controls. The results were analyzed according to receiver operating characteristic (ROC) curve. Results The levels of cTnI and CK-MB in AMI group was higher than control group(P 〈 0.01 ). 2 to 10 h after AMI, the area under ROC curve were 0.925,0. 991,0.998,0.648,0.719 and 0.831 respectively. The borderline value of sensitivity of cTnI and CK-MB from 2 to 10 h after AMI were 90.6%, 97.6% ,97.7% ,54. 1% ,56.9% and 76.9% respectively. The specificity were 87.3% ,95.4% ,98.5% ,87.3%, 93.5% and 88.1% respectively. If the level of cTnI was higher than 20.1 μg/L in 10 h after AMI, there was a good relativity between cTnI and myocardial reinfarction ( r = 0.74). Conclusions The cTnI detection is use for early diagnosis of AMI and may predict myocardial reinfarction.
出处 《检验医学》 CAS 北大核心 2007年第4期406-408,共3页 Laboratory Medicine
关键词 肌钙蛋白Ⅰ 急性心肌梗死 诊断 心肌再梗死 Cardiac troponin Ⅰ Acute myocardial infarction Diagnosis Myocardial reinfarction
  • 相关文献

参考文献4

二级参考文献22

  • 1王文畅,王华庆.中国非免疫规划疫苗接种现状和影响因素浅析[J].中国疫苗和免疫,2020,0(1):93-97. 被引量:65
  • 2毛振兴,叶晓丹,李万仓,张速进,陈琦.温州市鹿城区2011-2017年出生儿童部分非免疫规划疫苗接种率监测[J].中国疫苗和免疫,2020,0(1):88-92. 被引量:7
  • 3Wu AHB, Apple FS, Gibler WB. et al. National Academy of Clinical Biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases[J]. Clin Chem, 1999,45 : 1104-1121.
  • 4Panteghini M, Apple FS, Christenson RH, et al. Proposal from IFCC committee on standardization of markers of cardiac damage (C-SMCD) : Recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes[J]. Scan J Clin Lab Invest, 1999,59 : 103-112.
  • 5The Joint European Society of Cardiology/American college of cardiology Committee. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American college of cardiology Committee for the redefinition of myocardial infarction[ S].J Am Coll Cardial, 2000,36:959-969.
  • 6Hamm CW. Cardiac-specific troponins in acute coronary syndromes[M]. In: Heart disease, ed. E Braunwald.WB Saunders coy, Philadelphia, 1997.
  • 7Dean KJ. Biochemistry and molecular biology of troponin Ⅰ and T[M]. In: Cardiac markers, ed. AHB Wu. Humana Press Inc. New Jersey, 1998. 193-204.
  • 8Montague C, Kirehfr T. Myoglobin in the early evaluation of acute chest pain[J]. Am J Clin Pathol, 1995,104:472-476.
  • 9Christenson RH, Vaidya H, Landt Y, et al. Standardization of CK-MB mass assay: the use of recombinant CK-MB as a reference material[J]. Clin Chem, 1999,45 : 1414-1423.
  • 10曹王丽,王如伟,方玲,胡江宁,金朱明.治疗性疫苗国内外研发现状与发展趋势[J].安徽农业科学,2013,41(36):13917-13919. 被引量:3

共引文献62

同被引文献24

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部